In this section
@article{Morris:2025:jtm/taaf017,
author = {Morris, KAL and Turner, H and Checkley, A and Ross, D and Chiodini, P},
doi = {jtm/taaf017},
journal = {Journal of Travel Medicine},
title = {Malaria chemoprophylaxis provision in the UK: a call to evaluate the cost-effectiveness and equity implications of universal provision},
url = {http://dx.doi.org/10.1093/jtm/taaf017},
volume = {32},
year = {2025}
}
TY - JOUR
AB - This position paper advocates for the re-evaluation of the cost-effectiveness and equity of National Health Service-subsidized malaria chemoprophylaxis, considering changes in UK malaria epidemiology, travel patterns, updated travel medicine guidance, novel Plasmodium falciparum treatment pathways and growing awareness and action to tackle sources of health inequities.
AU - Morris,KAL
AU - Turner,H
AU - Checkley,A
AU - Ross,D
AU - Chiodini,P
DO - jtm/taaf017
PY - 2025///
SN - 1195-1982
TI - Malaria chemoprophylaxis provision in the UK: a call to evaluate the cost-effectiveness and equity implications of universal provision
T2 - Journal of Travel Medicine
UR - http://dx.doi.org/10.1093/jtm/taaf017
UR - https://doi.org/10.1093/jtm/taaf017
VL - 32
ER -
For any enquiries related to the MRC Centre please contact:
Scientific Manager
Susannah Fisher
mrc.gida@imperial.ac.uk
External Relationships and Communications Manager
Dr Sabine van Elsland
s.van-elsland@imperial.ac.uk